Osteoporosis in men

Journal of the American Academy of Orthopaedic Surgeons

Volumn 14, Issue 6, 2006, Pages 347-353

  Wright, Vonda J ^a,b,c  

^a HOSPITAL FOR SPECIAL SURGERY   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN; MALE; OSTEOPOROSIS; REVIEW; RISK FACTOR;

HUMANS; MALE; OSTEOPOROSIS; RISK FACTORS;

EID: 33750712037     PISSN: 1067151X     EISSN: None     Source Type: Journal    
DOI: 10.5435/00124635-200606000-00004     Document Type: Review

References (54)

1. Bilezikian JP: Osteoporosis in men. J Clin Endocrinol Metab 1999;84: 3431-3434.
2. National Osteoporosis Foundation; America's Bone Health: The State of Osteoporosis and Low Bone Mass in Our Nation. Washington, DC: National Osteoporosis Foundation, 2002.
3. Kiebzak GM, Beinart GA, Perser K, Ambrose CG, Siff SJ, Heggeness MG: Undertreatment of osteoporosis in men with hip fracture. Arch Intern Med 2002;162:2217-2222.
4. Sernbo I, Johnell O: Consequences of a hip fracture: A prospective study over 1 year. Osteoporos Int 1993;3: 148-153.
5. Hannan MT, Felson DT, Anderson JJ: Bone mineral density in elderly men and women: Results from the Framingham Osteoporosis study. J Bone Miner Res 1992;7:547-553.
6. Looker AC, Orwoll ES, Johnston CC Jr, et al: Prevalence of low femoral bone density in older U.S. adults from NHANES III. J Bone Miner Res 1997; 12:1761-1768.
7. Olszynski WP, Davison SK, Adachi JD, et al: Osteoporosis in men: Epidemiology, diagnosis, prevention, and treatment. Clin Ther 2004;26:15-28.
8. Melton LJ III, Thamer M, Ray NF: Fractures attributable to osteoporosis: Report from the National Osteoporosis Foundation. J Bone Miner Res 1997;12:16-23.
9. Chang KP, Center JR, Nguyen TV, Eisman JA: Incidence of hip and other osteoporotic fractures in elderly men and women: Dubbo Osteoporosis Epidemiology Study. J Bone Miner Res 2004;19:532-536.
10. Trombetti A, Herrmann F, Hoffmeyer P, Schurch MA, Bonjour JP, Rizzoli R: Survival and potential years of life lost after hip fracture in men and age-matched women. Osteoporos Int 2002;13:731-737.
11. Melton LJ III, Chrischilles EA, Cooper C, Lane AW, Riggs BL: How many women have osteoporosis? J Bone Miner Res 1992;7:1005-1010.
12. Ray NF, Chan JK, Thainer M, Melton JL III: Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995: Report from the National Osteoporosis Foundation. J Bone Miner Res 1997;12:24-35.
13. Seeman E, Bianchi G, Adami S, Kanis J, Khosla S, Orwoll E: Osteoporosis in men: Consensus is premature. Calcif Tissue Int 2004;75:120-122.
14. Gullberg B, Johnell O, Kanis JA: World-wide projections for hip fracture. Osteoporos Int 1997;7:407-413.
15. Lombardi A, Ross PD: The assessment of bone mass in men. Calcif Tissue Int 2001;69:222-224.
16. Orwoll ES: Osteoporosis in men. Endocrinol Metab Clin North Am 1998;27:349-367.
17. Amin S, Felson DT: Osteoporosis in men. Rheum Dis Clin North Am 2001;27:19-47.
18. Melton LJ III, Kan SH, Frye MA, Wahner HW, O'Fallon WM, Riggs BL: Epidemiology of vertebral fractures in women. Am J Epidemiol 1989;129: 1000-1011.
19. Licata A: Osteoporosis in men: Suspect secondary disease first. Cleve Clin J Med 2003;70:247-254.
20. Beck TJ, Looker AC, Ruff CB, Sievanen H, Wahner HW: Structural trends in the aging femoral neck and proximal shaft: Analysis of the Third National Health and Nutrition Examination Survey dual-energy X-ray absorptiometry data. J Bone Miner Res 2000;15:2297-2304.
21. Riggs BL, Melton LJ III, Robb RA, et al: Population-based study of age and sex differences in bone volumetric density, size, geometry, and structure at different skeletal sites. J Bone Miner Res 2004;19:1945-1954.
22. Bakhireva LN, Barrett-Connor E, Kritz-Silverstein D, Morton DJ: Modifiable predictors of bone loss in older men: A prospective study. Am J Prev Med 2004;26:436-442.
23. Tanaka T, Latorre MR, Jaime PC, Florindo AA, Pippa MG, Zerbini CA: Risk factors for proximal femur osteoporosis in men aged 50 years or older. Osteoporos Int 2001;12:942-949.
24. Smith EP, Boyd J, Frank GR, et al: Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. N Engl J Med 1994;331:1056-1061.
25. Morishima A, Grumbach MM, Simpson ER, Fisher C, Qin K: Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens. J Clin Endocrinol Metab 1995;80:3689-3698.
26. Brenton DP, Dow CJ, James JI, Hay RL, Wynne-Davies R; Homocystinuria and Marfan's syndrome: A comparison. J Bone Joint Surg Br 1972;54: 277-298.
27. Bischoff H, Freitag P, Jundt G, Steinmann B, Tyndall A, Theiler R: Type I osteogenesis imperfecta: Diagnostic difficulties. Clin Rheumatol 1999; 18:48-51.
28. Felson DT, Kiel DP, Anderson JJ, Kannel WB: Alcohol consumption and hip fractures: The Framingham Study. Am J Epidemiol 1988;128:1102-1110.
29. Ward KD, Klesges RC: A meta-analysis of the effects of cigarette smoking on bone mineral density. Calcif Tissue Int 2001;68:259-270.
30. Lipworth BJ: Systemic adverse effects of inhaled corticosteroid therapy: A systematic review and meta-analysis. Arch Intern Med 1999;159:941-955.
31. Van Staa TP, Leufkens HG, Abenhaim L, Zhang B, Cooper C: Use of oral corticosteroids and risk of fracture. J Bone Miner Res 2000;15:993-1000.
32. Zaqqa D, Jackson RD: Diagnosis and treatment of glucocorticoid-induced osteoporosis. Cleve Clin J Med 1999; 66:221-230.
33. Smith MR, McGovern FJ, Zietman AL, et al: Pamidronate to prevent bone loss during androgen-deprivation therapy for prostate cancer. N Engl J Med 2001;345:948-955.
34. Stanley HL, Schmitt BP, Poses RM, Deiss WP: Does hypogonadism contribute to the occurrence of a minimal trauma hip fracture in elderly men? J Am Geriatr Soc 1991;39:766-771.
35. Reed BY, Zerwekh JE, Sakhaee K, Breslau NA, Gottschalk F, Pak CY: Serum IGF 1 is low and correlated with osteoblastic surface in idiopathic osteoporosis. J Bone Miner Res 1995; 10:1218-1224.
36. Szulc P, Munoz F, Claustrat B: Bioavailable estradiol may be an important determinant of osteoporosis in men: The MINOS Study. J Clin Endocrinol Metab 2001;86:192-199.
37. van den Beld AW, de Jong FH, Grobbee DE, Pols HA, Lamberts SW: Measures of bioavailable serum testosterone and estradiol and their relationships with muscle strength, bone density, and body composition in elderly men. J Clin Endocrinol Metab 2000;85: 3276-3282.
38. Amin S, Zhang Y, Swain CT: Association of hypogonadism and estradiol levels with bone mineral density in older men from the Framingham study. Ann Intern Med 2000;133: 951-963.
39. Barrett-Connor E, Mueller JE, von Mühlen DG, Laughlin GA, Schneider DL, Sartoris DJ: Low levels of estradiol are associated with vertebral fractures in older men, but not women: The Rancho Bernardo study. J Clin Endocrinol Metab 2000;85:219-223.
40. Khosla S, Melton LJ III, Atkinson EJ, O'Fallon WM, Klee GG, Riggs BL: Relationship of serum sex steroid levels and bone turnover markers with bone mineral density in men and women: A key role for bioavailable estrogen. J Clin Endocrinol Metab 1998;83: 2266-2274.
41. Falahati-Nini A, Riggs BL, Atkinson EJ, O'Fallon WM, Eastell R, Khosla S: Relative contributions of testosterone and estrogen in regulating bone resporption and formation in normal elderly men. J Clin Invest 2000;106: 1553-1560.
42. Braidman I, Baris C, Wood L, et al: Preliminary evidence for impaired estrogen receptor-α protein expression in osteoblasts and osteocytes from men with idiopathic osteoporosis. Bone 2000;26:423-427.
43. NIH Consensus Conference: Optimal calcium intake: NIH Consensus Development Panel on Optimal Calcium Intake. JAMA 1994;272:1942-1948.
44. Klibanski A, Campbell-Adams L, Bassford T, Blair SN, Boden SD, Dickersin K: NIH consensus development conference statement: Osteoporosis prevention, diagnosis and therapy. NIH Consensus Statement 2000; 17: 1-45.
45. Orwoll ES, Meier DE: Alterations in calcium, vitamin D, and parathyroid hormone physiology in normal men with aging: Relationship to the development of senile osteopenia. J Clin Endocrinol Metab 1986;63:1262-1269.
46. Kujala UM, Kaprio J, Kannus P, Sarna S, Koskenvuo M: Physical activity and osteoporotic hip fracture risk in men. Arch Intern Med 2000;160:705-708.
47. Campion JM, Maricic MJ: Osteoporosis in men. Am Fam Physician 2003; 67:1521-1526.
48. Orwoll E, Ettinger M, Weiss S, et al: Alendronate for the treatment of osteoporosis in men. N Engl J Med 2000;343:604-610.
49. Ringe JD, Faber H, Farahmand P, Dorst A: Efficacy of risedronate in men with primary and secondary osteoporosis: Results of a 1-year study. Rheumatol Int 2006;26:427-431.
50. Rubin MR, Cosman F, Lindsay R, Bilezikian JP: The anabolic effects of parathyroid hormone. Osteoporos Int 2002;13:267-277.
51. Slovik DM, Rosenthal DI, Doppelt SH, et al: Restoration of spinal bone in osteoporotic men by treatment with human parathyroid hormone (1-34) and 1,25-dihydroxyvitamin D. J Bone Miner Res 1986;1:377-381.
52. Kurland ES, Cosman F, McMahon DJ, Rosen CJ, Lindsay R, Bilezikian JP: Parathyroid hormone as a therapy for idiopathic osteoporosis in men: Effects on bone mineral density and bone markers. J Clin Endocrinol Metab 2000;85:3069-3076.
53. Orwoll ES, Scheele WH, Paul S, et al: The effect of teriparatide [human parathyroid hormone (1-34)] therapy on bone density in men with osteoporosis. J Bone Miner Res 2003;18:9-17.
54. Finkelstein JS, Hayes A, Hunzelman JL, Wyland JJ, Lee H, Neer RM: The effects of parathyroid hormone, alendronate, or both in men with osteoporosis. N Engl J Med 2003;349: 1216-1226.